From neurodegeneration to neurohomeostasis: the role of ubiquitin - PubMed (original) (raw)
Review
From neurodegeneration to neurohomeostasis: the role of ubiquitin
R John Mayer. Drug News Perspect. 2003 Mar.
Abstract
Several years ago ubiquitin immunocytochemistry first demonstrated that ubiquitin protein conjugates are present in intraneuronal inclusions in all the major human chronic neurodegenerative diseases, as well as in inclusions in cerebellar astrocytomas and in hepatocytes in alcoholic liver disease. Unexpectedly, further studies showed that Lewy bodies are present in the cortex. Lewy bodies were originally described in the brain stem and are pathogonomic in the neuropathological diagnosis of Parkinson's disease. A balanced interpretation of further elegant experimental approaches, including transgenesis, suggests that the formation of intraneuronal inclusions is cytoprotective. Putative oligomeric proaggregates (prefibrillar entities) of cellular proteins inhibit the 26S proteasome and promote apoptosis. In the last few years a clutch of distinct experimental approaches have focused on the roles of ubiquitin-related processes in the development of the nervous system and neurohomeostasis. It is now clear that the ubiquitin/proteasome system (UPP) has a pivotal role in synaptogenesis, the formation of neuromuscular junctions and neurotransmitter receptor function. The inhibitory GABA(A) receptor, alpha1 glycine receptor, beta(2)-adrenergic receptor and arrestin, opiate receptors and the excitatory metabotropic glutamate receptor (mGluR1alpha) are regulated by the UPP. It is also increasingly clear that the regulation of long-term synaptic plasticity, and therefore memory, is dependent on both protein synthesis and protein degradation. Therefore, for the first time we have the opportunity to dissect the substrate of memory and the basis of cognitive decline in aging and in chronic neurodegenerative disease. Clearly, further understanding will provide a platform for novel drug development to treat chronic neurodegenerative diseases, including Alzheimer- and Parkinson-related conditions, and possibly psychiatric disorders.
(c) 2003 Prous Science. All rights reserved.
Similar articles
- Immunocytochemical co-localization of the proteasome in ubiquitinated structures in neurodegenerative diseases and the elderly.
Ii K, Ito H, Tanaka K, Hirano A. Ii K, et al. J Neuropathol Exp Neurol. 1997 Feb;56(2):125-31. doi: 10.1097/00005072-199702000-00002. J Neuropathol Exp Neurol. 1997. PMID: 9034365 - Failure of the ubiquitin-proteasome system in Parkinson's disease.
McNaught KS, Olanow CW, Halliwell B, Isacson O, Jenner P. McNaught KS, et al. Nat Rev Neurosci. 2001 Aug;2(8):589-94. doi: 10.1038/35086067. Nat Rev Neurosci. 2001. PMID: 11484002 Review. No abstract available. - UCH-L1 aggresome formation in response to proteasome impairment indicates a role in inclusion formation in Parkinson's disease.
Ardley HC, Scott GB, Rose SA, Tan NG, Robinson PA. Ardley HC, et al. J Neurochem. 2004 Jul;90(2):379-91. doi: 10.1111/j.1471-4159.2004.02485.x. J Neurochem. 2004. PMID: 15228595 - The role of the ubiquitin-proteasomal pathway in Parkinson's disease and other neurodegenerative disorders.
Chung KK, Dawson VL, Dawson TM. Chung KK, et al. Trends Neurosci. 2001 Nov;24(11 Suppl):S7-14. doi: 10.1016/s0166-2236(00)01998-6. Trends Neurosci. 2001. PMID: 11881748 Review. - Damage control--a possible non-proteolytic role for ubiquitin in limiting neurodegeneration.
Gray DA. Gray DA. Neuropathol Appl Neurobiol. 2001 Apr;27(2):89-94. doi: 10.1046/j.1365-2990.2001.00321.x. Neuropathol Appl Neurobiol. 2001. PMID: 11437989 Review.
Cited by
- Effect of divalent metals on the neuronal proteasomal system, prion protein ubiquitination and aggregation.
Kanthasamy AG, Choi C, Jin H, Harischandra DS, Anantharam V, Kanthasamy A. Kanthasamy AG, et al. Toxicol Lett. 2012 Nov 15;214(3):288-95. doi: 10.1016/j.toxlet.2012.09.008. Epub 2012 Sep 17. Toxicol Lett. 2012. PMID: 22995398 Free PMC article. - Processing of optineurin in neuronal cells.
Shen X, Ying H, Qiu Y, Park JS, Shyam R, Chi ZL, Iwata T, Yue BY. Shen X, et al. J Biol Chem. 2011 Feb 4;286(5):3618-29. doi: 10.1074/jbc.M110.175810. Epub 2010 Nov 8. J Biol Chem. 2011. PMID: 21059646 Free PMC article. - The understudied links of the retromer complex to age-related pathways.
Wilson KA. Wilson KA. Geroscience. 2022 Feb;44(1):19-24. doi: 10.1007/s11357-021-00430-1. Epub 2021 Aug 9. Geroscience. 2022. PMID: 34370162 Free PMC article. - Natural toxins implicated in the development of Parkinson's disease.
Salama M, Arias-Carrión O. Salama M, et al. Ther Adv Neurol Disord. 2011 Nov;4(6):361-73. doi: 10.1177/1756285611413004. Ther Adv Neurol Disord. 2011. PMID: 22164190 Free PMC article. - Case Report: Contiguous Xq22.3 Deletion Associated with ATS-ID Syndrome: From Genotype to Further Delineation of the Phenotype.
Smetana J, Vallova V, Wayhelova M, Hladilkova E, Filkova H, Horinova V, Broz P, Mikulasova A, Gaillyova R, Kuglík P. Smetana J, et al. Front Genet. 2021 Oct 29;12:750110. doi: 10.3389/fgene.2021.750110. eCollection 2021. Front Genet. 2021. PMID: 34777475 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical